retatrutide glp-1 medication clinical trials weight loss New obesity drug, retatrutide, shows added benefits Retatrutide Peptide: The Breakthrough Triple-Hormone – Retatrutide Obesity Triple Agonist Targeting

The benefits of extended lifespan and a deferred onset of age-related disorders in humans are a common observation and can be attributed to the drop in basal metabolic rate and reduced oxidative stress on cells due to decreased production of ROS in individuals [134, 135]

Retatrutide data from investigational trials

11 Exenatide has been associated with hypoglycemia when given in combination with metformin, SUs, and TZDs

This is known as a drug-condition interaction

The agency emphasized that compounded products are not FDAapproved and cannot be marketed as such

Protection Against Collagen Breakdown Environmental stressors and oxidative damage don't just prevent new collagen formation